Novonesis (Novozymes) A/S B
Novonesis (Novozymes) A/S B/ DK0060336014 /
NSIS/B
|
2024-07-24 12:00:00 AM
|
Chg.
+11.40
|
Volume |
Bid5:10:00 PM |
Ask5:10:00 PM |
Market Capitalization |
Dividend Y. |
P/E Ratio |
|
431.90DKK
|
+2.71%
|
496,377
Turnover: 205.99 mill. |
431.70Bid Size: - |
432.00Ask Size: - |
119 bill.DKK |
0.98% |
39.29 |
Fundamentals
| |
FY 2023 |
Growth (1Y) |
| Per Share |
|
| Earnings per Share: |
10.92 DKK |
-17.83% |
| EPS Diluted: |
- DKK |
-17.51% |
| Revenues per Share: |
64.54 DKK |
2.49% |
| Book Value per Share: |
50.40 DKK |
1.54% |
| Cash Flow per Share: |
14.97 DKK |
4.17% |
| Dividend per Share: |
4.20 DKK |
-30.00% |
| Total |
in mill. |
|
| Revenues: |
17,899.00 DKK |
1.97% |
| Net Income: |
3,024.00 DKK |
-17.96% |
| Operating Cash Flow: |
4,152.00 DKK |
- |
| Cash and Cash Equivalents: |
1,116.00 DKK |
- |
Valuation Ratios
| |
Current |
Latest FY* |
| P/E Ratio: |
39.29 |
33.98 |
| P/S Ratio: |
6.65 |
5.75 |
| P/BV ratio: |
8.51 |
7.36 |
| P/CF Ratio: |
28.66 |
24.79 |
| PEG: |
-2.20 |
-1.91 |
| Earnings Yield: |
2.54% |
2.94% |
| Dividend Yield: |
0.98% |
1.13% |
| Market Capitalization |
|
| Market Capitalization: |
119 bill. DKK |
102.91 bill. DKK |
| Free Float Market Cap.: |
- DKK |
- DKK |
| Market Cap. / Employee: |
17.61 mill. DKK |
15.23 mill. DKK |
| Shares Outstanding: |
277.32 mill. |
|
Profitability
| Gross Profit Margin: |
54.32% |
| EBIT Margin: |
22.21% |
| Net Profit Margin: |
16.89% |
| Return on Equity: |
21.63% |
| Return on Assets: |
10.65% |
Financial Strength
| Liquidity I / Cash Ratio: |
15.37% |
| Liquidity II / Quick Ratio: |
66.35% |
| Liquidity III / Current Ratio: |
130.29% |
| Debt / Equity Ratio: |
103.11% |
| Dynam. Debt / Equity Ratio: |
347.13% |
Efficiency
| Employees: |
6,756 |
| Personal Expenses / Employee: |
- DKK |
| Revenues / Employee: |
2,649,348.73 DKK |
| Net Income / Employee: |
447,602.13 DKK |
| Total Assets / Employee: |
4,202,338.66 DKK |
| * Fiscal Year End: |
2023-12-31 |
| Accounting Standard: |
IFRS |
